{"slug":"hanmi-pharm","name":"한미약품","name_en":"Hanmi Pharm.","ticker":"128940.KS","updated_at":"2026-07-11T10:21:56.592+00:00","canonical":"https://valuechain.wiki/hanmi-pharm","kicker":"코스피 대형주","kicker_en":"KOSPI large cap","lead":"신약 개발과 개량신약에 강한 국내 대표 제약 기업이다. 코스피 시가총액 상위 종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A leading Korean pharma strong in new-drug development and incrementally modified drugs. KOSPI large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"전문의약품"},{"name":"해외·기술수출"},{"name":"북경한미(중국)"}],"total":"약 1.5조원 (FY2024)"},"segments_en":{"parts":[{"name":"Prescription drugs"},{"name":"Overseas and licensing"},{"name":"Beijing Hanmi (China)"}],"total":"~₩1.5T (FY2024)"},"returns_yearly":{"2021":-34.1,"2022":6.5,"2023":28.5,"2024":-24.3,"2025":98.4,"2026":-19.3},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}